Some of the key facts of the Chronic Wounds Market Report:
The Chronic Wounds market size across the 7MM was valued at approximately USD 9,000 million in 2023.
The Chronic Wounds market in the United States was valued at approximately USD 6,000 million in 2023.
In 2023, the 7MM accounted for approximately 12 million diagnosed prevalent cases of Chronic Wounds.
The prevalent cases of Chronic Wounds by type are segmented into Pressure Ulcers, Diabetic Foot Ulcers, Venous Ulcers, and other types. In the US, Pressure Ulcers accounted for 38% of cases, Diabetic Foot Ulcers for 35%, Venous Ulcers for 18%, and other types for 9%.
Key Chronic Wounds Companies: Biotissue, PolarityTE, RHEACELL GmbH & Co. KG, Smith & Nephew, Kaken Pharmaceutical, MediWound, Paracrine, Inc., Oneness Biotech, Anterogen Co., Ltd., TR Therapeutics, and others.
Key Chronic Wounds Therapies: Regranex (becaplermin), Fiblast (trafermin), ON101, TTAX01, revyve® Antimicrobial Wound Cleanser, and others.
The Chronic Wounds market is expected to surge due to the disease’s increasing prevalence and aging population during the forecast period. Furthermore, launching various multiple-stage Chronic Wounds pipeline products will significantly revolutionize the Chronic Wounds market dynamics.
Chronic Wounds Overview
Chronic wounds are defined as wounds with an inability to heal within an anticipated time frame. They are widespread and frequently mistreated. A wound is considered chronic or non-healing when it has not fully healed even after four to six weeks of screening. Venous ulcers (VU), diabetic foot ulcers (DFU), and pressure ulcers (PU) are examples of common chronic wound types. Chronic wounds are influenced by factors such as underlying health conditions, wound location, the presence of infection, and individual genetic factors.
Get a Free sample for the Chronic Wounds Market Forecast, Size & Share Analysis Report
Chronic Wounds Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Chronic Wounds Epidemiology Segmentation:
The Chronic Wounds market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
Total Prevalent Cases of Chronic Wounds
Total Diagnosed Prevalent Cases of Chronic Wounds
Type-specific Cases of Chronic Wounds
Total Prevalence of Chronic Wounds by Geographic Region
Total Prevalence of Chronic Wounds by Underlying Etiology
Download the report to understand which factors are driving Chronic Wounds epidemiology trends @ Chronic Wounds Epidemiology Forecast
Chronic Wounds Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Wounds market or expected to get launched during the study period. The analysis covers Chronic Wounds market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Chronic Wounds Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Chronic Wounds Therapies and Key Companies
Regranex (becaplermin): Smith & Nephew
Fiblast (trafermin): Kaken Pharmaceutical
ON101: Oneness Biotech
TTAX01: Biotissue
revyve® Antimicrobial Wound Cleanser: Kane Biotech Inc.
Discover more about therapies set to grab major Chronic Wounds market share @ Chronic Wounds Treatment Landscape
Chronic Wounds Market Drivers
Rising Prevalence of Chronic Diseases: Increasing cases of diabetes, obesity, and vascular disorders contribute to a higher incidence of chronic wounds, boosting market demand.
Aging Population: Growth in the elderly population, who are more prone to wounds such as pressure ulcers and diabetic foot ulcers, drives market expansion.
Advancements in Wound Care Products: Introduction of advanced dressings, bioengineered skin substitutes, and negative pressure wound therapy stimulates adoption.
Rising Awareness and Early Diagnosis: Enhanced patient education, physician awareness, and early intervention strategies improve treatment uptake.
Healthcare Infrastructure and Reimbursement Policies: Better healthcare access and supportive insurance coverage encourage timely treatment, further expanding market growth.
Chronic Wounds Market Barriers
Scarcity of epidemiology data, resulting in a limited understanding of disease prevalence and limiting healthcare planning.
Lack of reliable biomarkers for wound healing, restricting the ability to accurately predict healing trajectories.
High treatment and care costs, which may limit access and reimbursement in certain regions.
Complexity and variability of wound healing processes among different patients, making it difficult to predict and manage healing trajectory effectively.
Scope of the Chronic Wounds Market Report
Coverage: 7MM
Study Period: 2020-2034
Forecast Period: 2024-2034
Key Chronic Wounds Companies: Biotissue, PolarityTE, RHEACELL GmbH & Co. KG, Smith & Nephew, Kaken Pharmaceutical, MediWound, Paracrine, Inc., Oneness Biotech, Anterogen Co., Ltd., TR Therapeutics, and others
Key Chronic Wounds Therapies: Regranex (becaplermin), Fiblast (trafermin), ON101, TTAX01, and others
Chronic Wounds Therapeutic Assessment: Chronic Wounds current marketed and Chronic Wounds emerging therapies
Chronic Wounds Market Dynamics: Chronic Wounds market drivers and Chronic Wounds market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Chronic Wounds Unmet Needs, KOL’s views, Analyst’s views, Chronic Wounds Market Access and Reimbursement
To Know in detail about the Chronic Wounds market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Wounds Market Forecast
Table of Contents
Key Insights
Report Introduction
Chronic Wounds Market Overview at a Glance
Chronic Wounds Market: Future Perspective
Executive Summary of Chronic Wounds
Key Events
Disease Background and Overview
Epidemiology and Patient Population
Patient Journey
Marketed Drugs
Emerging Drugs
Chronic Wounds: Market Analysis
KOL Views
SWOT Analysis
Unmet Needs
Market Access and Reimbursement
Appendix
DelveInsight Capabilities
Disclaimer
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kanishk KumarEmail: Send EmailPhone: +14699457679Address:304 S. Jones Blvd #2432 City: Las VegasState: https://www.delveinsight.com/Country: United StatesWebsite: https://www.delveinsight.com/
